HOME >> MEDICINE >> NEWS
Melanoma Patients' Sentinel Lymph Nodes (SLNS) Play A Strong Role In Disease Prognosis, UCSF Study Reports

ATLANTA -- Researchers at the University of California San Francisco report that melanoma patients whose cancer has spread to their sentinel lymph nodes (SLNs) have a greater chance of experiencing disease recurrence and mortality compared to those whose cancer has not advanced to their SLNs.

The sentinel lymph node (SLN) earned its name because it is the first region in a person's body that receives cancer cells from the place where the disease originated. After cancer cells drain to the SLN, the disease may spread, or metastasize, to other regions of the body. Lymph nodes are the body's first line of defense against infections and cancers. They produce infection-fighting lymphocytes that are distributed via the lymphatic system that functions as a channel of freeways throughout the body.

"Sentinel lymph nodes are a strong marker for predicting a patient's outcomes in regards to disease recurrence and death due to advanced melanoma," says Stanley P.L. Leong, MD, FACS, UCSF professor of surgery and director of the Sentinel Lymph Node program in the UCSF Cancer Center. "We found that patients who have a positive SLN biopsy are more likely to experience a disease recurrence and die from melanoma than those with a negative SLN biopsy."

Leong will present data on the role of SLNs in melanoma today at the American Society for Clinical Oncology (ASCO) meeting.

During the UCSF study, a total of 358 advanced melanoma patients underwent a selective SLN dissection and were followed for a median period of 546 days.

Leong reports that for patients whose cancer spread to their SLNs and therefore had a positive SLN biopsy (63), 78 percent had no evidence of disease and 22 percent experienced recurrent melanoma. Eighty-six percent of these patients remained alive and 14 percent (9) died from melanoma by the end of the study.

For patients with negative SLNs (295), 93 percent showed no evidence of disease and 7 percent developed a recurrence of the dis
'"/>

Contact: Abby Sinnot
asinnot@pubaff.ucsf.edu
415-885-7277
University of California - San Francisco
15-May-1999


Page: 1 2 3

Related medicine news :

1. Melanoma vaccine developed at the University of Virginia shows promise in clinical trial
2. University Of Pittsburgh Cancer Institute Defines First Immunologic Markers Of Interferon Effectiveness Against Melanoma
3. Jefferson Researchers Report Progress In Using Vaccinia-Based Vaccine For Melanoma
4. Vaccine Against Melanoma Proves Successful For Patients With Disease Spread To Two Lymph Node Areas
5. DNA-Based Cancer Vaccine Shows Promise To Successfully Treat Melanoma In Mice
6. Caregivers, remember this: Patients medications ease your distress too
7. Patients anaesthesia concerns reviewed
8. Heal thyself: Patients bone marrow cells restore failing hearts
9. Initial Avon/NCI breast cancer research grants awarded in Progress for Patients awards program
10. Patients beliefs and behaviors about health lifestyle and medications may help tailor high blood pressure management method
11. Relaxation And Music Significantly Reduce Patients Postoperative Pain

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/29/2020)... ... August 29, 2020 , ... When professor and author ... greater ease than most people would. Rather than become melancholic, however, he put together ... on achieving one’s dreams. Randy Pausch took a negative situation and turned it into ...
(Date:8/28/2020)... ... August 28, 2020 , ... WHAT , Hespiro™ is ... with respiratory conditions, including COVID-19, while reducing the need for scarce mechanical ventilators. ... exhaled gas and scrubs it free of carbon dioxide in a completely closed ...
(Date:8/28/2020)... ... August 28, 2020 , ... With ... set out to continue helping the specialty-diet community connect with great, gluten-free brands. ... get coupons, enter giveaways, chat with brands & watch over 50 educational classes... ...
(Date:8/28/2020)... ... 2020 , ... Ziegler, a specialty investment bank, is pleased ... Health, a tech-enabled behavioral health and well-being solutions provider. , Synchronous Health, ... intelligence (AI) to increase access and quality of behavioral health services, and Adventist ...
(Date:8/27/2020)... ... August 27, 2020 , ... Walk-in Dermatology’s ... team in its Greenvale, New York location. , Loren received her New ... She is certified in chemical peels, microdermabrasion, Hydrafacial MD, dermaplaning, facial lymphatic, and ...
Breaking Medicine News(10 mins):
(Date:9/2/2020)... WILMINGTON, Mass. (PRWEB) , ... September 02, 2020 ... ... in handheld 1064nm Raman technology, will moderate a roundtable discussion among industry professionals ... The roundtable will be hosted by American Pharmaceutical Review and will ...
(Date:9/1/2020)... ... 01, 2020 , ... Agilent, a global leader in life ... Technology Virtual Symposium 2020 (ASTVS 2020) on September 10-11, opening at 10:00am ... webinars and Networking sessions, with a vast array of on-demand presentations to enjoy ...
(Date:9/1/2020)... , ... September 01, 2020 , ... While coronavirus cases ... rate as businesses, schools and community organizations remain closed. Because about 80% of blood ... the help of both blood donors and blood drive hosts to ensure blood products ...
Breaking Medicine Technology:
Cached News: